Pilot-testing a Perinatal Palliative Care Intervention Program
Recruiting now · Not applicable
Conditions studied: Perinatal Palliative Care, Life-limiting Fetal Diagnosis, Life-limiting Neonatal Diagnosis
In brief
The objective of this pilot trial is to implement a new perinatal palliative care intervention program tailored to the Flemish context, which aims to provide care to parents who receive a severe foetal/neonatal diagnosis for their (unborn) child and to their healthcare providers. Additionally, we aim to evaluate the feasibility and preliminary effectiveness by comparing measured variables to the baseline measurement done in the same hospital wards beforehand.
Key facts
- Study ID
- NCT06456034
- Run by
- Vrije Universiteit Brussel
- People needed
- 20
- Starts
- 2025-05-18
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-09-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Parents:
- who receive a severe foetal diagnosis for their unborn child and decide to continue the pregnancy after 20 weeks of gestation , or
- who receive a severe foetal diagnosis for their unborn child after 20 weeks gestation and decide to terminate the pregnancy (with or without feticide) resulting in the stillbirth of their child
- Parents who receive a severe neonatal diagnosis for their live-born infant in the first week after birth
- Additional inclusion criteria for parents:
- Parents are either Dutch speaking, or are willing to participate with support from a (phone or real life) interpreter, in collaboration with the "Agentschap Integratie \& Inburgering"
- Parents are older than 18
- Parents are not suffering from an officially diagnosed psychiatric disorder prior to receiving the severe diagnosis of their child
- Parents are deemed (emotionally) approachable for the current study by the treating physician
- For each family included in the pilot study, the physicians and nurses/midwives who will be/are most closely involved in the care of the infant and the parents will also be asked to participate. If healthcare providers refuse to provide informed consent to participate in the study, their data will be deemed as missing for that case (parental outcomes are considered as the primary outcome measures).
Where it is running
- UZ Brussels — Brussels, Belgium (enrolling)
- UZ Gent — Ghent, Belgium
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.